Multiple sclerosis drugs on Prescription Blue Premium (S5584-002)
Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Michigan
- Premium
- $106.70/month
- Deductible
- None
3 of 8 Multiple sclerosis drugs are covered on this plan. All 3 require prior authorization.
5 aren't on the formulary, including Kesimpta and Vumerity.
- from $17.13Tier 4
- from $7.96Tier 3
- $75.47Tier 5
Not on the formulary
Kesimpta, Vumerity, Mayzent, Zeposia, Mavenclad
Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.